Cue Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 40.4%.

Top 25 shareholders own 25.49% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.89%	Bleichroeder LP	4,997,240	€5.8m	74.6%	1.35%
3.79%	Slate Path Capital LP	2,402,455	€2.8m	0%	0.04%
3.21%	The Vanguard Group, Inc.	2,031,421	€2.3m	0%	no data
1.58%	Park City Capital, LLC	1,000,000	€1.2m	0%	91.55%
1.48%	Bios Equity Partners LP	940,000	€1.1m	0%	0.98%
0.9%	BlackRock, Inc.	570,975	€658.3k	-24.6%	no data
0.8%	Geode Capital Management, LLC	508,827	€586.6k	3.32%	no data
0.76%	Robertson Stephens Wealth Management, LLC	478,500	€551.7k	0%	0.02%
0.63%	Sigma Planning Corporation	401,325	€462.7k	50.9%	0.01%
0.63%	Good Life Advisors, LLC	400,000	€461.2k	23.1%	0.03%
0.57%	Millennium Management LLC	358,974	€413.9k	-27.3%	no data
0.46%	GSA Capital Partners LLP	291,663	€336.3k	5.08%	0.02%
0.41%	Advisory Research, Inc.	257,225	€296.6k	0%	0.05%
0.38%	Bank of America Corporation, Asset Management Arm	239,202	€275.8k	-1.39%	no data
0.31%	Stifel Asset Management Corp.	194,222	€223.9k	0.12%	no data
0.28%	State Street Global Advisors, Inc.	177,053	€204.1k	0%	no data
0.27%	Aaron Glenn Fletcher	173,867	€200.4k	0%	no data
0.22%	Northern Trust Global Investments	138,314	€159.5k	-60.5%	no data
0.21%	Anish Suri	135,638	€156.4k	0%	no data
0.21%	Daniel Passeri	134,578	€155.2k	0%	no data
0.16%	Mf Capital Partners, Llc	100,000	€115.3k	0%	no data
0.13%	HighTower Advisors, LLC	83,284	€96.0k	0%	no data
0.12%	UBS Asset Management AG	74,175	€85.5k	25.7%	no data
0.053%	Morgan Stanley, Investment Banking and Brokerage Investments	33,692	€38.8k	-63.7%	no data
0.044%	Frank Morich	28,000	€32.3k	0%	no data